← All candidates
Six insider buys in the last year — $140.1K in all.
9 filings on record.
ICCCIMMUCELL CORP /DE/
NasdaqCM · Healthcare · $98.52M
$10.89
+0.31% · Sep 16
Six insider buys in the last year — $140.1K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 6 buys◆ 7 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ICCC ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$98.52M
Float
6.0M
66% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
3.3
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
President and CEO
te Boekhorst Paul Francis Olivier
Bought $76.0K on Jun 18 — 8,000 sh @ $9.50, held direct, 45% of their stake.
First Form 4 on file
Director
Tomsche David Scott
Bought $7.8K on Nov 25 — 1,633 sh @ $4.77, held indirect, 35% of their stake.
First Form 4 on file
Director
Gathagan Bryan K.
Bought $6.3K on Jun 12 — 1,000 sh @ $6.32, held direct, 100% of their stake.
First Form 4 on file
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
3 more transactions on Pro →Context
Earnings · EPS vs forecast
2 of 4 quarters beat
Q4 '20$0.03 act+$0.07
Q3 '20−$0.04 act+$0.04
Q2 '20−$0.11 act−$0.01
Q1 '20−$0.02 act
Coverage
The Zacks Analyst Blog Highlights JPMorgan, Novartis, Qualcomm, Genie and ImmuCellZacks · 06-26ICCC's Valuation Remains Premium: Is it Worth Overpaying for?Zacks · 06-18ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong DemandZacks · 05-25ImmuCell Corp (ICCC) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic GrowthGuruFocus.com · 05-15
The file stays open
9 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice